Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$8.8 million.

  • Onconetix's Income from Continuing Operations fell 12949.5% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.1 million, marking a year-over-year increase of 479.69%. This contributed to the annual value of -$58.7 million for FY2024, which is 5688.72% down from last year.
  • Per Onconetix's latest filing, its Income from Continuing Operations stood at -$8.8 million for Q3 2025, which was down 12949.5% from -$2.4 million recorded in Q2 2025.
  • Onconetix's Income from Continuing Operations' 5-year high stood at -$2.4 million during Q2 2025, with a 5-year trough of -$29.4 million in Q4 2024.
  • Its 3-year average for Income from Continuing Operations is -$10.5 million, with a median of -$8.5 million in 2025.
  • In the last 5 years, Onconetix's Income from Continuing Operations plummeted by 29058.53% in 2024 and then surged by 8341.75% in 2025.
  • Over the past 3 years, Onconetix's Income from Continuing Operations (Quarter) stood at -$22.4 million in 2023, then crashed by 31.64% to -$29.4 million in 2024, then skyrocketed by 70.16% to -$8.8 million in 2025.
  • Its Income from Continuing Operations was -$8.8 million in Q3 2025, compared to -$2.4 million in Q2 2025 and -$8.5 million in Q1 2025.